Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
78,914,349
-
Total 13F shares
-
44,093,053
-
Share change
-
+4,306,723
-
Total reported value
-
$66,599,038
-
Put/Call ratio
-
87%
-
Price per share
-
$1.51
-
Number of holders
-
93
-
Value change
-
-$4,537,335
-
Number of buys
-
58
-
Number of sells
-
35
Institutional Holders of Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN) as of Q4 2025
As of 31 Dec 2025,
Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN) was held by
93 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,093,053 shares.
The largest 10 holders included
BVF INC/IL, VANGUARD GROUP INC, BlackRock, Inc., Defilade Capital Management, L.P., Ensign Peak Advisors, Inc, Zimmer Partners, LP, SPHERA FUNDS MANAGEMENT LTD., Blue Owl Capital Holdings LP, ADAR1 Capital Management, LLC, and Jefferies Financial Group Inc..
This page lists
93
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.